Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


Cancer Vaccines

15 Sep 2014 - 16 Sep 2014 - London, UK



Bookmark and Share


Quantify Strategies to Enhance Cancer Vaccine Research and Development

The global therapeutic cancer vaccines market is expected to grow to a value of $7.8 billion by 2019. As companies look to develop new drugs to enter this rapidly growing industry, Cancer Vaccines 2014 will mark the path forward in terms of cancer vaccine research, clinical development and regulation.

SMi Group have worked closely with an expert speaker panel which includes KOLs from Amal Therapeutics, Amgen, DanDrit Biotech, CureVac and Vaccinogen, to put together an exciting conference agenda for the 3rd annual conference taking place on 15th and 16th September in London UK.

This year's programme will feature a mix of case study led presentations, networking opportunities, an interactive workshop and keynote addresses that have been tailored for an audience of professionals working in the cancer vaccine market from drug design through to clinical trials and treatment.

Previous Testimonials Include:

"Great focused meeting. Good range of speakers and topics" – INSERM

"I found the conference very informative and the standard of the presentations was very good. I’m pleased that I attended" - Asterand

Key Speakers Include:

Joseph Melenhorst, Director of the Product Development & Correlative Sciences Laboratory, University Of Pennsylvania

Tom Lillie, Therapeutic Area Head, Oncology, Amgen Ltd

Alex Karlsson-Parra, CSO, Immunicum AB

Birgit Scheel, Director Program Management Oncology, Curevac GmbH

Harpreet Singh, Managing Director, Founder and CSO, Immatics Biotechnologies GmbH

Christian Ottensmeier, Professor in Experimental Cancer Medicine, University Of Southampton

Madiha Derouazi, CEO, Amal Therapeutics

Eric Leire, CEO, DanDrit Biotech

Why Attend in 2014?

Insight into a Perfect Partnership – University of Pennsylvania and Novartis Collaboration! Hear it here first: Assessing techniques involved in removing a patient's T cells and inserting new genetic material to enable the T cells to attack and kill cancer cells

Assessing Oncolytic Vaccines - Reviewing developments from Amgen and Psioxus Therapeutics

What are the key questions in Cancer Immunotherapy? Professor Christian Ottensmeier attacks this question head on!

Evaluating analytical advances for Cancer Vaccines with an insight from Key Opinion Leaders at Immatics GmbH, Vaccinogen and the University of Southampton

To register or download a brochure visit: 

http://www.smi-online.co.uk/goto/2014cancervaccinesevent24.asp 

For further details, contact Sajid Goraya on +44 (0)20 7827 6148 or email sgoraya@smi-online.co.uk 



Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
A Diversity of Genomes
New DNA from understudied groups reveals modern genetic variation, ancient population shifts.
“Sixth Sense” May Be More Than Just A Feeling
The NIH Study shows that two young patients with a mutation in the PIEZ02 have problems with touch and proprioception, or body awareness.
Gene Could Reduce Female Mosquitoes
Virginia Tech researchers have found a gene that can reduce female mosquitoes over many generations.
Biomolecular Manufacturing ‘On-the-Go’
Wyss Institute team unveils a low-cost, portable method to manufacture biomolecules for a wide range of vaccines, other therapies as well as diagnostics.
Improving Crop Efficiency with CRISPR
New study of CRISPR-Cas9 technology from Virginia Tech shows potential to improve crop efficiency.
Fighting Cancer with Sticky Nanoparticles
Treatment that uses bioadhesive nanoparticles drug carriers proved more effective than conventional treatments for certain cancers.
Stem Cell ‘Heart Patch’ Almost Perfected
Scientists aiming to perfect and test 3D "heart patches" in animal model, last hurdle before human patients.
Fighting Plant Pathogens with RNA
Researchers develop strategy that could lead to environmentally friendly fungicide to fight pathogens.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!